PDB Short entry for 2OQ1 HEADER TRANSFERASE 30-JAN-07 2OQ1 TITLE TANDEM SH2 DOMAINS OF ZAP-70 WITH 19-MER ZETA1 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ZAP-70; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 3-256; COMPND 5 SYNONYM: 70 KDA ZETA-ASSOCIATED PROTEIN, SYK-RELATED TYROSINE KINASE; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: T-CELL SURFACE GLYCOPROTEIN CD3 ZETA CHAIN; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: RESIDUES 69-87; COMPND 12 SYNONYM: T-CELL RECEPTOR T3 ZETA CHAIN, CD247 ANTIGEN; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 MOL_ID: 2; SOURCE 8 SYNTHETIC: YES; SOURCE 9 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HOMO SAPIENS SOURCE 10 (HUMANS) KEYWDS TANDEM SH2 DOMAINS, ZAP-70, TYROSINE KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.H.HATADA,E.R.LAIRD,J.GREEN,J.MORGENSTERN,M.K.RAM REVDAT 4 27-DEC-23 2OQ1 1 REMARK SEQADV REVDAT 3 24-JUL-19 2OQ1 1 REMARK LINK REVDAT 2 24-FEB-09 2OQ1 1 VERSN REVDAT 1 06-MAR-07 2OQ1 0 JRNL AUTH M.H.HATADA,X.LU,E.R.LAIRD,J.GREEN,J.P.MORGENSTERN,M.LOU, JRNL AUTH 2 C.MARR,T.B.PHILLIPS,M.K.RAM,K.THERIAULT JRNL TITL MOLECULAR BASIS FOR THE INTERACTION OF ZAP-70 WITH THE JRNL TITL 2 T-CELL RECEPTOR JRNL REF NATURE V. 377 32 1995 JRNL REFN ISSN 0028-0836 JRNL PMID 7659156 JRNL DOI 10.1038/377032A0 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.843 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 23697 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2369 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2197 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 114 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.99 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.580 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2OQ1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000041445. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : GRAPHITE MONOCHROMATOR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23978 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: MLPHARE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20%PEG 4000, 50MM SODIUM CITRATE,100 REMARK 280 MM AMMONIUM ACETATE, 20MM DTT, PH 6.2, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 31.68500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13870 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 PB PB A 1119 O HOH A 582 2647 1.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 204 CA - CB - CG ANGL. DEV. = 14.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 102 104.73 72.90 REMARK 500 LYS A 253 -95.65 -122.84 REMARK 500 PRO A 257 174.11 -52.85 REMARK 500 GLN B 302 -146.90 -165.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 CYSTEINE 119 IS MODIFIED WITH TRIMETHYL LEAD ACETATE. REMARK 600 CARBONS OF METHYLS ARE MISSING FROM THE MODEL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PB A 1119 DBREF 2OQ1 A 5 258 UNP P43403 ZAP70_HUMAN 3 256 DBREF 2OQ1 B 301 319 UNP P20963 CD3Z_HUMAN 69 87 SEQADV 2OQ1 MSE A 31 UNP P43403 MET 29 MODIFIED RESIDUE SEQADV 2OQ1 MSE A 124 UNP P43403 MET 122 MODIFIED RESIDUE SEQADV 2OQ1 MSE A 163 UNP P43403 MET 161 MODIFIED RESIDUE SEQADV 2OQ1 PTR B 304 UNP P20963 TYR 72 MODIFIED RESIDUE SEQADV 2OQ1 PTR B 315 UNP P20963 TYR 83 MODIFIED RESIDUE SEQRES 1 A 254 ASP PRO ALA ALA HIS LEU PRO PHE PHE TYR GLY SER ILE SEQRES 2 A 254 SER ARG ALA GLU ALA GLU GLU HIS LEU LYS LEU ALA GLY SEQRES 3 A 254 MSE ALA ASP GLY LEU PHE LEU LEU ARG GLN CYS LEU ARG SEQRES 4 A 254 SER LEU GLY GLY TYR VAL LEU SER LEU VAL HIS ASP VAL SEQRES 5 A 254 ARG PHE HIS HIS PHE PRO ILE GLU ARG GLN LEU ASN GLY SEQRES 6 A 254 THR TYR ALA ILE ALA GLY GLY LYS ALA HIS CYS GLY PRO SEQRES 7 A 254 ALA GLU LEU CYS GLU PHE TYR SER ARG ASP PRO ASP GLY SEQRES 8 A 254 LEU PRO CYS ASN LEU ARG LYS PRO CYS ASN ARG PRO SER SEQRES 9 A 254 GLY LEU GLU PRO GLN PRO GLY VAL PHE ASP CYS LEU ARG SEQRES 10 A 254 ASP ALA MSE VAL ARG ASP TYR VAL ARG GLN THR TRP LYS SEQRES 11 A 254 LEU GLU GLY GLU ALA LEU GLU GLN ALA ILE ILE SER GLN SEQRES 12 A 254 ALA PRO GLN VAL GLU LYS LEU ILE ALA THR THR ALA HIS SEQRES 13 A 254 GLU ARG MSE PRO TRP TYR HIS SER SER LEU THR ARG GLU SEQRES 14 A 254 GLU ALA GLU ARG LYS LEU TYR SER GLY ALA GLN THR ASP SEQRES 15 A 254 GLY LYS PHE LEU LEU ARG PRO ARG LYS GLU GLN GLY THR SEQRES 16 A 254 TYR ALA LEU SER LEU ILE TYR GLY LYS THR VAL TYR HIS SEQRES 17 A 254 TYR LEU ILE SER GLN ASP LYS ALA GLY LYS TYR CYS ILE SEQRES 18 A 254 PRO GLU GLY THR LYS PHE ASP THR LEU TRP GLN LEU VAL SEQRES 19 A 254 GLU TYR LEU LYS LEU LYS ALA ASP GLY LEU ILE TYR CYS SEQRES 20 A 254 LEU LYS GLU ALA CYS PRO ASN SEQRES 1 B 19 ASN GLN LEU PTR ASN GLU LEU ASN LEU GLY ARG ARG GLU SEQRES 2 B 19 GLU PTR ASP VAL LEU ASP MODRES 2OQ1 MSE A 31 MET SELENOMETHIONINE MODRES 2OQ1 MSE A 124 MET SELENOMETHIONINE MODRES 2OQ1 MSE A 163 MET SELENOMETHIONINE MODRES 2OQ1 PTR B 304 TYR O-PHOSPHOTYROSINE MODRES 2OQ1 PTR B 315 TYR O-PHOSPHOTYROSINE HET MSE A 31 8 HET MSE A 124 8 HET MSE A 163 8 HET PTR B 304 16 HET PTR B 315 16 HET PB A1119 1 HETNAM MSE SELENOMETHIONINE HETNAM PTR O-PHOSPHOTYROSINE HETNAM PB LEAD (II) ION HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 MSE 3(C5 H11 N O2 SE) FORMUL 2 PTR 2(C9 H12 N O6 P) FORMUL 3 PB PB 2+ FORMUL 4 HOH *114(H2 O) HELIX 1 1 SER A 18 ALA A 29 1 12 HELIX 2 2 GLY A 81 ASP A 92 1 12 HELIX 3 3 GLY A 115 LYS A 134 1 20 HELIX 4 4 GLU A 136 ALA A 159 1 24 HELIX 5 5 HIS A 160 MSE A 163 5 4 HELIX 6 6 THR A 171 SER A 181 1 11 HELIX 7 7 THR A 233 LYS A 244 1 12 HELIX 8 8 ASN B 308 ARG B 312 5 5 SHEET 1 A 4 PHE A 36 GLN A 40 0 SHEET 2 A 4 TYR A 48 HIS A 54 -1 O SER A 51 N LEU A 37 SHEET 3 A 4 ARG A 57 ARG A 65 -1 O ILE A 63 N TYR A 48 SHEET 4 A 4 TYR A 71 ILE A 73 -1 O ALA A 72 N GLU A 64 SHEET 1 B 4 LYS A 188 PRO A 193 0 SHEET 2 B 4 THR A 199 TYR A 206 -1 O ALA A 201 N ARG A 192 SHEET 3 B 4 THR A 209 GLN A 217 -1 O TYR A 211 N LEU A 204 SHEET 4 B 4 TYR A 223 CYS A 224 -1 O CYS A 224 N SER A 216 LINK C GLY A 30 N MSE A 31 1555 1555 1.33 LINK C MSE A 31 N ALA A 32 1555 1555 1.33 LINK C ALA A 123 N MSE A 124 1555 1555 1.33 LINK C MSE A 124 N VAL A 125 1555 1555 1.33 LINK C ARG A 162 N MSE A 163 1555 1555 1.33 LINK C MSE A 163 N PRO A 164 1555 1555 1.34 LINK C LEU B 303 N PTR B 304 1555 1555 1.33 LINK C PTR B 304 N ASN B 305 1555 1555 1.32 LINK C GLU B 314 N PTR B 315 1555 1555 1.33 LINK C PTR B 315 N ASP B 316 1555 1555 1.32 LINK SG CYS A 119 PB PB A1119 1555 1555 2.62 SITE 1 AC1 1 CYS A 119 CRYST1 50.110 63.370 54.000 90.00 114.44 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019956 0.000000 0.009069 0.00000 SCALE2 0.000000 0.015780 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020341 0.00000